The National Council on Problem Gambling issued a strongly worded warning Tuesday about the harms from prediction markets, taking a firmer stance on the industry following months of criticism for its initial handling.
Why it matters: Kalshi joined the nonprofit in May — the first prediction market to do so — setting off concerns among some problem gambling groups over NCPG's approach to the fast growing industry.
The willingness to confront powerful health care interests is becoming a litmus test for candidates in congressional battleground races with six weeks to go before the midterm elections.
Why it matters: Forget the old Affordable Care Act wars. Anxiety over health care costs is driving a new brand of populism, as Republicans and Democrats try to outdo each other with tough messages about taking on drug companies, insurers, pharmacy benefit managers and other industries.
Illinois Gov. JB Pritzker told "CBS Mornings" that he's been on GLP-1s since 2024 and has lost 80 pounds.
Why it matters: Pritzker said the treatment has made him feel "a whole lot different and a whole lot better," as he faces growing attention as a potential 2028 Democratic presidential candidate.
Stopping Ozempic and other GLP-1 drugs may carry health risks beyond weight regain, according to a growing body of research.
Why it matters: Many patients stop GLP-1 treatment because of cost, side effects or other reasons, but emerging research suggests some cardiovascular and metabolic benefits can fade after treatment ends.
The Trump administration is wading into the difficult issue of mental health parity, laying out requirements aimed at making health plans cover behavioral health at the same level as physical health.
Why it matters: It's a sign that the administration could steer in a different direction from the Biden administration, which put a focus on compliance reporting that the Trump team is rejecting.
